Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
The purpose of this study is to evaluate two different treatment strategies in patients admitted to hospital with Community Acquired Pneumonia. The investigators hypothesize treatment according to both procalcitonin (PCT) and C-reactive protein (CRP) will be effective in reducing the length of antibiotic treatment.
100 项与 PulmoScience, Inc. 相关的临床结果
0 项与 PulmoScience, Inc. 相关的专利（医药）
100 项与 PulmoScience, Inc. 相关的药物交易
100 项与 PulmoScience, Inc. 相关的转化医学
